Deep Dive: Reducing CV Risk Beyond LDL in Secondary Prevention

Published Date: 02 Jun 2026

The 2026 ACC/AHA Dyslipidemia Guideline has set a numerical LDL-C target for secondary prevention. Now what?

Read Full News

Latest News

Funding Cuts Drive Sharp Drop in HIV Prevention, UNAIDS Says

Almost 40% fewer people got a drug to help prevent HIV infection in 2025 than in the previous year, as global aid funding cuts ⁠hit preventive services particularly hard,...

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Ebola Testing Stalled in Three Congo Labs Due to Shortages, Says WHO

Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Neurological Effects of Ebola Persist Years After Infection

Despite partial recovery, neurological symptoms persist for years after infection in some adult survivors of Ebola, a prospective study showed.

In Congo, Doctors Face Ebola With Little Protection

Harrowing scenes are unfolding at health facilities at the epicenter of an Ebola outbreak in the Democratic Republic of Congo.

Congo Says Number Of Confirmed Ebola Cases Rises to Nearly 600

The Democratic Republic of Congo on Tuesday said confirmed Ebola cases had climbed to nearly 600, ⁠raising awareness within the local population about the importance of...

Todays Updates

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D.

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored.

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Off-Label Rxs: Thinking Out of the Box for Skin Diseases

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.

Todays Updates

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D.

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored.

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Off-Label Rxs: Thinking Out of the Box for Skin Diseases

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.

Latest News

Almost 40% fewer people got a drug to help prevent HIV infection in 2025 than in the previous year, as global aid funding cuts ⁠hit preventive services particularly hard,...

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Despite partial recovery, neurological symptoms persist for years after infection in some adult survivors of Ebola, a prospective study showed.

Harrowing scenes are unfolding at health facilities at the epicenter of an Ebola outbreak in the Democratic Republic of Congo.

The Democratic Republic of Congo on Tuesday said confirmed Ebola cases had climbed to nearly 600, ⁠raising awareness within the local population about the importance of...

News All Time

US to Re-engage With Gavi Vaccine Alliance Amid Ebola Outbreak, Rubio Says

U.S. Secretary of State Marco Rubio said on Tuesday that the U.S. would re-engage with the global vaccine alliance Gavi amid the Ebola outbreak in several African...

Flesh-eating Screwworm Found Within 31 Miles of US Border, Says USDA

A devastating parasitic fly that eats warm-blooded animals alive and could cause millions of dollars in economic ⁠damage to the U.S. economy has been found in a young sheep...

Trump Signs Order to Use HHS Vaccine Assessment as Federal Guide

U.S. President Donald Trump signed an executive order to ⁠acknowledge a recent scientific assessment by the Department of Health and Human ⁠Services on childhood vaccines as...

US Regulator Approves Oral Drug From Japan's Shionogi to Prevent COVID-19

Japan's Shionogi & Co said on Monday ⁠the U.S. Food and Drug Administration has approved ⁠its oral antiviral Ensitrelvir, commercially known as ⁠Xocova, for the...

WHO Identifies Ebola Treatments & Vaccines for Testing

The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.

FDA Advisers Recommend COVID Vaccines Be Updated to Target Current Dominant Variant

The U.S. FDA's advisory panel recommended on Thursday that COVID-19 vaccines for 2026-2027 immunization should be updated to target ⁠the dominant XFG variant, despite some...

Medicine Renamed Many Diseases: Why Rename PCOS?

The proposed PMOS terminology reframes PCOS by emphasizing the psychological, dermatologic, reproductive, and metabolic features linked to the condition.

US CDC Seeks Staff for Ebola Screening as Outbreak Response Expands

The U.S. Centers for Disease Control and Prevention has asked staff to volunteer for urgent deployment to support ⁠Ebola screening at the country's entry points, according...

mRNA Shot Offers Efficacy for Influenza-Like Illness

In older adults, a single dose of the mRNA-1010 vaccine shows superior efficacy to the standard-dose inactivated seasonal influenza vaccine in the prevention of influenza-like illness.

Red Cross Mourns Death of Three Volunteers From Ebola

The Red Cross on Saturday paid tribute to three volunteers who ⁠are believed to have died after contracting Ebola while handling bodies.

US Adds Atlanta Area Airport for Ebola Screening, CDC Says

Americans coming back from the Democratic Republic of the Congo, ⁠Uganda or South Sudan now have a second entry point for returning ⁠to the United States, with the CDC on...

US FDA Advisers to Weigh Updating 2026-27 COVID Vaccines for XFG Variant

Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest circulating XFG ⁠subvariant for the 2026-27...

Shingles Shot Shows Short-Term Safety in People With HIV

In people living with HIV, the adjuvanted recombinant subunit herpes zoster vaccine shows a favorable short-term safety and tolerability profile.

Inside an African Lab That Helped Crack the Hantavirus Outbreak

(Clarifies status of Istitut Pasteur de Dakar in paragraphs 6, 8-9)

Chikungunya in Pregnancy Raises Infant Hospital Risk

A cohort study of births in Brazil found increased hospitalization risk through age 3 after maternal chikungunya; results inform global surveillance and vaccination strategies.

US Working With Small Biotech Firm on Experimental Ebola Treatment, HHS Official Says

U.S. officials are working with Mapp Biopharmaceutical to make an experimental Ebola treatment available for people who may have been exposed to ⁠the virus, an HHS official...

Recommended News For You

Patients value communication skills from cancer surgeons across six key areas, according to research

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

a brand-new generic therapy for different types of cancer.

BTK Inhibitor Active in Half of Patients With Richter Transformation

Drop in credit score after cancer diagnosis linked to increased mortality

Recommended Articles For You

Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After  

Phosphate Vs. Phosphorus: What Is The Difference? 

Environmental Carcinogen Exposure Screening: Advances, Clinical Implications, and Guideline-Based Approaches 

Essential Developments in Oncology for Healthcare Excellence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

EMA OKs Two Treatments for Small Cell Lung Cancer

2.

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

3.

Cancer care crowdfunding increasingly common, but rarely successful

4.

A video animation guide to assist young people who are fatigued from cancer.

5.

Muscular strength and good physical fitness linked to lower risk of death in people with cancer

1.

Studying Lactic Acid in Pediatric Tumor Microenvironments: Experimental Approaches Explored

2.

How EPCORITAMAB is Revolutionizing the Treatment of Cancer

3.

Exploring the Latest Treatments for Essential Thrombocythemia

4.

A New Perspective on Spherocytosis: Uncovering Innovative Treatments

5.

Modern Applications in Oncology in the Digital Era

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

3.

Efficient Management of First line ALK-rearranged NSCLC - Part V

4.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

5.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot